Evidence for dopamine autoreceptors controlling dopamine synthesis in the substantia nigra
- PMID: 6800566
- DOI: 10.1016/0006-8993(82)90484-x
Evidence for dopamine autoreceptors controlling dopamine synthesis in the substantia nigra
Abstract
The effect of apomorphine and haloperidol on DOPA accumulation after inhibition of DOPA decarboxylase activity with NSD 1015 was compared in the substantia nigra (SN) and caudate nucleus (CN) of normal rats and rats deprived of nigral afferences from the striatum by means of intrastriatal kainic acid. In normal rats apomorphine decreased DOPA accumulation to the same extent in both the SN and CN. However, haloperidol produced a more pronounced increase in DOPA accumulation in the CN than in the SN. The effect of both drugs still persisted in the SN and CN after destruction of the neuronal strionigral feedback loop with kainic acid. The results provide evidence for the existence of nigral dopamine autoreceptors controlling dopamine synthesis in the SN.
Similar articles
-
Effect of dopamine agonists and antagonists on DOPA formation in the substantia nigra.J Neurochem. 1982 Jan;38(1):75-9. doi: 10.1111/j.1471-4159.1982.tb10855.x. J Neurochem. 1982. PMID: 6809898
-
Inhibition by apomorphine of the potassium-evoked release of [3H]-gamma-aminobutyric acid from the rat substantia nigra in vitro.Br J Pharmacol. 1981 Oct;74(2):389-97. doi: 10.1111/j.1476-5381.1981.tb09983.x. Br J Pharmacol. 1981. PMID: 7317688 Free PMC article.
-
The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.Naunyn Schmiedebergs Arch Pharmacol. 1991 Jul;344(1):16-28. doi: 10.1007/BF00167378. Naunyn Schmiedebergs Arch Pharmacol. 1991. PMID: 1663587
-
Agonist--antagonist interaction on dopamine receptors in brain, as reflected in the rates of tyrosine and tryptophan hydroxylation.J Neural Transm. 1977;40(2):99-113. doi: 10.1007/BF01250562. J Neural Transm. 1977. PMID: 323424 Review.
-
Parkinson's disease: from brain homogenate to treatment.Fed Proc. 1973 Feb;32(2):183-90. Fed Proc. 1973. PMID: 4143953 Review. No abstract available.
Cited by
-
Ventral tegmental area: site through which dopamine D2-receptor agonists evoke behavioural and electrocortical sleep in rats.Br J Pharmacol. 1988 Nov;95(3):860-6. doi: 10.1111/j.1476-5381.1988.tb11715.x. Br J Pharmacol. 1988. PMID: 2974741 Free PMC article.
-
Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder.Pharmacol Ther. 2020 Sep;213:107583. doi: 10.1016/j.pharmthera.2020.107583. Epub 2020 May 27. Pharmacol Ther. 2020. PMID: 32473160 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources